Oslo University Hospital has secured €4.9 million in European Union funding to advance care models for older people with cancer, underscoring a growing policy focus on the complex needs of ageing populations. The development was reported by Innovation News Network in an article titled “Oslo University Hospital secures €4.9 million EU grant for older cancer patient care,” which detailed plans to strengthen personalised, multidisciplinary treatment pathways for this rapidly expanding patient group.
The grant is expected to support a multi-year research and implementation effort aimed at integrating geriatric assessment more systematically into oncology. Clinicians and researchers at Oslo University Hospital will collaborate with international partners to refine tools that identify frailty, comorbidities, and functional limitations—factors that often determine how older patients tolerate and benefit from cancer therapies. By embedding these insights into routine clinical decision-making, the project seeks to move beyond one-size-fits-all treatment toward approaches calibrated to biological rather than chronological age.
Europe’s demographic shift has intensified the urgency of such work. Older adults account for a growing share of cancer diagnoses, yet they remain underrepresented in clinical trials, contributing to gaps in evidence on optimal dosing, treatment sequencing, and supportive care. The initiative will attempt to close some of these gaps by generating data on outcomes that matter particularly to older patients, including quality of life, independence, and the risk of treatment-related complications.
A central component of the programme involves closer coordination between oncologists, geriatricians, nurses, and allied health professionals. By aligning expertise across disciplines, the project aims to ensure that treatment plans reflect a comprehensive view of patient health, including cognitive status, nutrition, and social support. Digital tools and standardized assessment frameworks are also expected to play a role in scaling these practices across participating centres.
The funding, provided through an EU research framework programme, reflects broader efforts in Brussels to promote innovation in healthcare systems facing rising demand and constrained resources. Projects that combine clinical research with practical implementation strategies have been prioritized, with an emphasis on interventions that can be adopted widely across member states.
If successful, the Oslo-led initiative could influence clinical guidelines and reimbursement models, particularly by demonstrating the value of upfront geriatric assessment in reducing hospitalizations and avoiding overtreatment. It may also help establish benchmarks for incorporating patient-reported outcomes into routine oncology care.
As highlighted by Innovation News Network, the grant positions Oslo University Hospital as a key contributor to Europe’s response to the challenges of cancer care in older adults. The project’s findings are expected to inform both policy and practice, with potential implications extending beyond oncology to the management of other age-related conditions where treatment complexity and patient heterogeneity present similar challenges.
